EX-2.1
from 425
130 pages
Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Agreement and Plan of Merger Among Infinity Pharmaceuticals, Inc., Mei Pharma, Inc. and Meadow Merger Sub, Inc. Dated as of February 22, 2023
12/34/56
EX-2.1
from 8-K
130 pages
Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Agreement and Plan of Merger Among Infinity Pharmaceuticals, Inc., Mei Pharma, Inc. and Meadow Merger Sub, Inc. Dated as of February 22, 2023
12/34/56
EX-2.1
from 10-Q
108 pages
Business Transfer Agreement Between Biofrontera Discovery Gmbh Waldhofer Str. 104, D-69127 Heidelberg, Germany („seller”) and Equity Neunte Vermögensverwaltungs Gmbh (Künftig: Discovery Partners International Gmbh) Kaiser-Joseph-Strasse 284, D-79098 Freiburg, Germany (“Buyer”) and Biofrontera AG Hemmelrather Weg 201, 51377 Leverkusen, Germany („seller’s Guarantor”) and Discovery Partners International AG Gewerbestrasse 16 Ch-4123 Allschwil, Switzerland
12/34/56
